3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
22
Pancreatic Neoplasms
9
Colonic Neoplasms
8
Burkitt Lymphoma
8
Stomach Neoplasms
5
Neoplasm Metastasis
5
Esophageal Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Rectal Neoplasms
4
Cholangiocarcinoma
4
Adenocarcinoma Of Esophagus
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Neoplasms
3
Lung Neoplasms
3
Endometrial Neoplasms
3
Adenocarcinoma
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Leukemia, Biphenotypic, Acute
2
Down Syndrome
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Small Bowel Adenocarcinoma
1
Interventions
fludarabine phosphate
2
fludarabine
2
blinatumomab
2
Cyclophosphamide
2
tislelizumab
1
tisagenlecleucel
1
obinutuzumab
1
Radiotherapy
1
Monatide (IMS 3015)
1
HMPL-013
1
Cetuximab
1
Blood Specimen Collection
1
Biological Assay
1
AP 1903 reagent
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Leucovorin
×
30 days
×
Clear all
No trials found.